Episodes

In the 25 episodes of Health:Further, three major themes have emerged. Firstly, macroeconomic forces are exerting significant pressure on the healthcare industry, with inflation negatively affecting health systems and the actions of the Federal...

Welcome to Episode 24 of Health:Further, where we dive into pressing healthcare issues and industry news. In this episode, we explore the challenges and innovations surrounding opioid treatment on the streets of Philadelphia. We also discuss three key...

Welcome to Episode 24 of Health:Further, where we dive into pressing healthcare issues and industry news. In this episode, we explore the challenges and innovations surrounding opioid treatment on the streets of Philadelphia. We also discuss three key...

In this episode, Marcus and Vic discussed several significant events currently taking place. One notable development is the closure of many Carta startups, indicating a challenging period for the industry. Additionally, Representative Matt Gaetz's...

In Episode 22 of Health:Further, we'll be covering a range of topics, including: Rite Aid plans to shutter stores in bankruptcy, and private equity-owned healthcare companies are merging in a $3 billion deal. The broken business model in the...

In Episode 21 of Health:Further, we'll be covering a range of topics, including: - "Republicans and the Lifesaving Government Initiative": Twenty years ago, the Republican Party initiated a groundbreaking government program that has had a profound...

In episode 20 of Health:Further, we'll be covering some interesting topics, including: - Walgreens teaming up with Pearl Health, a primary care enablement tech company, to expand its efforts in value-based care. - The steep rise in health insurance...

Episode 19 was recorded during the https://www.aspeninstitute.org/programs/health-innovators-fellowship/ Reunion in Chicago, IL. This special episode is presented in partnership with https://www.portalinnovations.com/ and their podcast,...

In episode 18 of Health:Further, we will dive into various topics. Firstly, we will examine the 4.20 percent increase in the Redbook Index in the United States for the week ending August 26, 2023, compared to the same week in …

In episode 17, we will be discussing various topics including the recent developments in Truepill, a startup that handles the shipment of prescription drugs for online pharmacies like Hims, Mark Cuban's Cost Plus Drugs, and GoodRx. According to a...

The fastest growing company in the US is solving healthcare's biggest challenge. Many health systems are pulling back from venture capital. The consequences of Medicaid's unwinding of continuous coverage are overwhelming. Prior authorization reduction...

The Bureau of Labor Statistics reported that the CPI rose 3.2% in July from year-ago levels, a slight increase from June’s 3.0%, but well below last summer’s peak of 9.1%. Americans’ collective credit-card bill rose to $1.03 trillion from $986 …

CA Nonprofit Hospitals are turning to bankruptcy for leverage against the State. Markets are pointing down after Fitch Ratings downgraded the United States’ AAA long-term credit rating. While CVS Health is cutting approx. 5,000 jobs to save on costs...

The Federal Reserve issues FOMC statement suggesting that economic activity has been expanding at a moderate pace. Analysts warn that bankruptcies and defaults could jump as the world adjusts to higher interest rates. Regional lenders are cutting back...

Vic interviews his friend Grant Chamberlain, Senior Managing Director, Healthcare Investment Banking at Ziegler. Grant has over 30 years of investment banking experience and had dedicated the majority of his career to advising HCIT and tech-enabled...

The Fed’s regulatory chief recently weighed in on a path to improvement following a string of midsize bank failures. Eli Lilly’s Retatrutide medication was recently under the WSJ spotlight for its surprising results. Rite Aid’s stock just hit a record...

Marcus interviews his fellow national HFMA board member, Dave Johnson, founder and CEO of 4Sight Health. Dave is a prolific writer on healthcare's pro-market transformation. He is the author-in-residence at MATTER, the Chicago-based healthcare...

SCOTUS has rejected use of race in higher education, which brings up a reflection on what we learned during the pandemic and the result of compounding generational discrimination. A new MDMA PTSD treatment is on the rise, while the health …

Vic Gatto and Marcus Whitney cover an array of trending topics including the Aledade capital raise, the letter from Senators Warren and Welch to Amazon regarding Amazon Clinic, the ASGE AI Task Force, and more.

Vic Gatto and Marcus Whitney are joined by special guest Aaron Gani from BehaVR, Inc. for a discussion on the Digital Therapeutics space. We're also covering the "hawkish" Fed pause, a sign of increasing patient volumes from UHG, and more.

Vic Gatto and Marcus Whitney discuss the Sequoia Capital split, the NEDA Chatbot mishap, Optum's bid for Amedisys, and more.

Vic Gatto and Marcus Whitney cover recent trending topics in healthcare including the Theranos scandal, CommonSpirit’s quarterly report, VC news from WSJ, the PCE index increase, and more.

Vic Gatto and Marcus Whitney explore the recent sale of Pear Therapeutics and what this situation means for the road ahead in the digital therapeutics space. Also included in the discussion is an in-depth look at a recent call to …

Vic Gatto and Marcus Whitney discuss recent developments in healthcare including details around the KKR/Envision bankruptcy situation, the debt ceiling crisis, advancements in AI tech and impact on healthcare, and more.